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Abstract
Background Hypothermic perfusion (HP) of the liver is
applied during total vascular exclusion (TVE) to reduce
ischemic injury during liver resection. No studies have been
performed comparing different perfusion solutions for HP.
The aim of this experimental study was to compare Ringer-
lactate solution (RL) with Celsior solution (Cs) for HP in a
pig model of 60-min TVE.
Method Twenty pigs underwent 60-min TVE of the liver.
Groups were TVE without HP (no-HP, n=9), TVE with HP
using RL (n=6), and TVE with HP using Cs (n=5). Blood
and liver tissue samples were taken before TVE and during
24-h reperfusion.
Results In the no-HP group, plasma aspartate amino-
transferase values were significantly increased during
reperfusion (p<0.05), while liver tissue pO2 levels (p<
0.01) were decreased when compared to the HP groups.
After 24-h reperfusion, bile production and liver tissue
glutathione content were significantly higher (p<0.05) in
the Cs group (42.0±1.7 mL/h and 44.9±2.2 nmol/mg, re-
spectively) as compared to the RL group (31.5±3.5 mL/h and
19.6±1.8 nmol/mg, respectively).
Conclusion The protective effect of HP during TVE was
confirmed in this study. HP with Cs was more effective in
reducing ischemic injury as compared to HP with RL.
Keywords Hypothermic perfusion .
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Introduction
Total vascular exclusion (TVE) consists of clamping of the
portal vein, the hepatic artery, and the supra and infrahe-
patic caval vein [1]. It is applied during extended liver
resection when backflow from the caval vein causes
significant blood loss or when part of the caval vein is
involved in the tumor. TVE leads to hepatic ischemia and
subsequent reperfusion (I–R) injury when the clamps are
removed and normal blood flow to the liver is restored.
Especially in patients with underlying liver disease, hepatic
ischemia for periods longer than 60 min leads to increased
risk of liver failure and death [2–4]. Liver I–R injury is
caused by the release of reactive oxygen species and the
onset of an inflammatory response by Kupffer cells. This
leads to further damage of the parenchymal and sinusoidal
endothelial cells, leading to necrosis, apoptosis, and
microcirculatory failure [5, 6].
In situ hypothermic perfusion (HP) of the liver during
TVE is an option to reduce hepatic I–R injury during
extensive liver resections [7–12]. The protective effect of
HP is based on the concept that hypothermia leads to
diminished metabolism and, hence, decreased energy and
oxygen demand. Ringer-lactate (RL) is one of the most
often used solutions for HP [7, 11]. It is a crystalloid
solution without any additives and without buffering
capacity. The aim of HP with Ringer-lactate solution is
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solely to cool the liver and thereby to decrease metabolism
and the need for oxygen. At 28°C, however, cellular
metabolism and oxygen demand is still around 50% [13].
Next to RL solution, organ preservation solutions have also
been applied during HP [8, 9]. The advantage of organ
preservation solutions lies in their ability to prevent tissue
acidosis, cell swelling, free radical damage, and energy
depletion, all phenomena which occur during ischemia and
subsequent reperfusion. A relatively new organ preserva-
tion solution, called Celsior (Cs) solution, has also shown
to be effective in both experimental and clinical organ
preservation [14–21]. It was originally designed for donor
heart and lung preservation but has also proven to be
suitable for the preservation of liver grafts [15, 18, 21]. Cs
contains reduced glutathione which has a strong antiox-
idative effect. Also, glutathione plays a role in preserving
endothelial function by enhancing endothelium-dependent
NO release, as has been demonstrated in pulmonary grafts
[22, 23]. Cs also contains mannitol and lactobionate to
prevent cell swelling and glutamate for energy supply.
Histidine buffer has been added to prevent tissue acidosis
and magnesium sulphate acts as a membrane stabilizer.
The aim of this study was to assess whether in situ HP
during TVE using Cs shows a benefit above RL solution in
terms of further diminishing liver damage and preserving
endothelial cell integrity and microcirculation. TVE with HP
using Cs or RL was also compared with TVE without HP.
Animals and methods
Animals
Twenty male pigs (Vendrig, Amsterdam, The Netherlands)
were used, weighing 40–50 kg. All pigs were allowed to
acclimatize to the laboratory environment for 7 days with
free access to standard laboratory food (Blok, Woerden,
The Netherlands) and water. Pigs were fasted overnight
with free access to water before the experiments. The
experiments were approved by the Animal Ethics Com-
mittee of the Academic Medical Center, University of
Amsterdam, The Netherlands.
Anesthesia
Methods concerning premedication and anesthesia were
described previously [12]. Blood temperature, measured in
the brachiocephalic vein, was continuously monitored and a
physiological body temperature of 37–38°C was main-
tained by means of a heating lamp and a heating mat.
Arterial blood gas analysis was performed before and at
regular intervals after TVE (ABL 505/OSM 3 HEMOXIM-
ETER®, Copenhagen, Denmark). Metabolic acidosis was
corrected with 8.4% HCO3
− (Fresenius Kabi Nederland B.
V.’s, Hertogenbosch, The Netherlands).
Surgical procedure
A midline laparotomy was performed followed by dissection
(ForceTM 20, Valleylab, Boulder, USA) and cannulation of
the common bile duct for continuous measurement of bile
production. Another cannula was placed into the distal com-
mon bile duct and the duodenum to return the bile to the
intestine of the animal during the experiment. The portal vein,
the hepatic artery, and the caval vein were dissected free and
the right gastric and the gastroduodenal artery were divided
together with the right gastric vein in order to cut off any
accessory blood supply to the liver. TVE was achieved by
clamping of the infra and suprahepatic caval vein, the com-
mon hepatic artery, and the portal vein. To prevent splanchnic
congestion and venous congestion in the lower limbs, a
situation that is lethal in pigs, a polyethylene prosthesis with
one side port was used to bypass blood from the infrahepatic
caval vein and portal vein to the suprahepatic caval vein
through a transverse incision in the infrahepatic caval vein.
The prosthesis was inserted and guided intralumenally in
cranial direction. It was fixed into the caval vein using two
slings, which were placed in suprahepatic as well as in
infrahepatic position. Then, the portal vein was divided and
the proximal end was connected to the side port of the
prosthesis after which the clamps were removed from the
caval vein and portal vein. The distal end of the portal vein
was used to perfuse the liver with cold RL or Cs solution.
The perfusate was allowed to drain through the transverse
incision of the caval vein into the abdominal cavity, from
where it was removed.
After 60 min of TVE, the perfusion was stopped and the
proximal portal vein was reconnected to the distal end. A
ligature was placed cranially from the side port around the
infrahepatic caval vein (to secure the intraluminal prosthesis
and to prevent blood from entering the abdominal cavity
after reperfusion of the liver) and the sling around the
suprahepatic caval vein was removed. The liver was then
reperfused by releasing the clamps from the portal vein and
the common hepatic artery and the abdomen was closed.
Experimental design
All 20 pigs underwent 60 min of TVE followed by 24 h of
reperfusion. The animals were randomly divided into three
groups. In the first group, TVE was performed without HP
(no-HP group; n=6). In the second group, livers were
perfused with ice-cold RL solution with an average core liver
temperature of 28°C (RL group; n=6). In the third group,
livers were perfused with ice-cold Cs solution also main-
taining an average core liver temperature of 28°C (Cs group;
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n=5). It was originally planned to have six animals in each
group. Three animals were added to the no-HP group
because three animals died before the end of the experiment,
making a total of 20 pigs (see “Results” section). Only the
six pigs that survived the whole experiment in the no-HP
group were used for data analysis. The Cs group only
included five animals because significant differences were
already found with five animals, and the Animal Ethics
Committee advised not to add the sixth animal to this group.
The components of the two perfusion solutions are
shown in Table 1. Total perfusion volumes were 5,100±467
mL in the RL group and 6,020±455 mL in the Cs group
(P=0.39). Core liver temperature was measured by two
temperature probes (Metatemp, Industrial Temperature
Measurement, Steenbergen, The Netherlands) and moni-
tored continuously (Thermistor 4070, Mallinckrodt, St.
Louis, USA). The probes were placed in the right lateral
and the left medial liver lobes. The tip was placed 4–5 cm
within the liver tissue.
The average temperature was used for adjusting the flow
of the perfusion solution. Perfusion was powered by a roller
pump (Gambro Instrumenta AB, Lund, Sweden) and the
flow was adjusted from 50 to 500 mL/h depending on the
core liver temperature. Flow was started at 100–200 mL/hr
and when the target core liver temperature was attained,
flow was adjusted to 50 mL/h, to maintain core liver
temperature at the desired level. In the group without
perfusion, liver temperature was maintained at 37–38°C.
After TVE and reperfusion, the pigs remained under
anesthesia for 24 h after which they were sacrificed.
Hepatocellular injury
To assess hepatocellular injury, aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) concentrations
were measured in arterial blood samples taken before TVE
and after 1, 6, 12, and 24 h of reperfusion using routine
laboratory techniques.
Hepatic pedicle blood flow
Portal vein and hepatic artery blood flow were monitored
continuously (Transonic Systems, A.B. Medical B.V.,
Roermond, The Netherlands).
Microvascular perfusion
Microvascular perfusion was assessed by performing intra-
hepatic tissue pO2 measurements using a polarographic pO2
needle electrode (SIGMA pO2-Histograph KIMOC, Eppen-
dorf, Hamburg, Germany), as described previously [24, 25].
A pO2 histogram was constructed from 100 consecutive
pO2 values obtained by stepwise withdrawal of the needle
over a 2-cm tract (pilgrim step method) in the right median
liver lobe. Intrahepatic pO2 measurements were performed
before TVE and after TVE at 10 min and 1 and 24 h.
Glutathione concentration
Glutathione concentrations were measured in liver tissue,
bile, and blood plasma according to the method of Tietze
[26]. Liver biopsies were taken from the rim of the right
medial liver lobe. The biopsies were homogenized in 1-mL
ice-cold phosphate-buffered saline. After protein determi-
nation (bicinchoninic acid protein assay, Pierce) in liver
tissue homogenates, 3.6 mL metaphosphoric acid (50 g/L)
was added to the homogenates, bile, and plasma samples
and the suspensions were vortexed and centrifuged
(4,500 rpm, 10 min). Supernatants were used for glutathione
measurements. Total (oxidized and reduced) glutathione
concentrations were measured before and 10 min and 1, 6,
and 24 h after TVE.
Coagulation parameters
Prothrombin time (PT) was determined using a one-stage
clotting assay and Thromborel-S thromboplastin (Dade
Behring, Leusden, The Netherlands). The plasma concen-
tration of thrombin–antithrombin complexes (TAT) were
measured by enzyme-linked immunosorbent assay (Enzyg-
nost TAT, Dade Behring, Leusden, The Netherlands).
Statistical analysis
Results are expressed as mean±standard error of the mean.
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS) 12.0.1 for Windows (SPSS Inc.,
Chicago, IL, USA). One-way analysis of variance (ANOVA)
followed by Bonferroni posttest was used for differences
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between groups. Repeated-measures ANOVA was used
for measurements at multiple time points followed by
Bonferroni posttest for differences between groups or
paired t-test for differences within groups at different time
points. A p-value<0.05 was considered significant.
Results
Survival
Three animals (33%) in the no-HP group died shortly after
TVE. Death in these animals was caused by massive
congestion of the liver leading to noncontrollable hypoten-
sive shock, highly elevated heart rate, and eventually
cardiac arrhythmia and arrest. To increase the sample size
in the no-HP group, three animals were added making a
total of n=6 in this group. No animals died during the
experiment in the other groups.
Arterial blood gas analysis
After reperfusion, the first arterial blood gas analysis was
performed at 10 min. Abnormal values found on these
analyses were immediately corrected by adjusting ventila-
tion (for pO2 or pCO2 abnormalities) and/or infusion of
HCO3
- (for metabolic acidosis). On these analyses, signif-
icantly lower arterial pH and base excess values were found
in the no-HP group and the RL group as compared to the
CE group (Table 2). In all groups, arterial pH and base
excess values were significantly lower after 10-min
reperfusion as compared to before TVE.
Parenchymal injury
AST was significantly elevated in the no-HP group as
compared to the RL group and the Cs group after TVE
(Fig. 1a). No statistical differences were found between the
RL group and the CE group. ALT values showed a similar
pattern (data not shown).
Vascular inflow into the liver
Decreased flow through the liver was found immediately
after reperfusion in animals that did not undergo HP.
Combined blood flow in the hepatic artery and the portal
Table 2 Arterial pH and base excess values before and after 10-min
reperfusion
no-HP (n=6)a RL (n=6) Cs (n=5)
Arterial pH
Pre-TVE 7.43±0.03a 7.43±0.02c 7.45±0.02e
10 min rep. 7.20±0.02ab 7.23±0.02cd 7.31±0.02bde
Arterial base excess (mmol/L)
Pre-TVE 3.1±1.6f 3.8±0.6h 3.5±1.3j
10-min rep. −7.7±0.4fg −6.7±0.4hi −4.1±0.9gij
Values with the same letters are significantly different (p<0.05).
a Only animals that survived the whole experiment are included.
Fig. 1 Aspartate aminotransferase (AST) levels (a), combined hepatic
artery and portal venous blood flow (b) and bile production (c), measured
before TVE, at the end of TVE (T), 10 min after TVE (R), and 1, 6, 12
and 24 h after TVE. a AST values were significantly lower in the RL
group and the Cs group compared to the no-HP group (** repeated
measures ANOVA, p=0.042). No differences in ASTwere found between
the RL group and the Cs group. b After 10-min reperfusion, blood flow
was significantly decreased in no-HP as compared to the other groups
(** p<0.02). No significant differences were found in blood flow on
the other time points. c Bile production was significantly higher in the
RL group and the Cs group as compared to the no-HP group at all
time points after TVE (** p<0.05). After 24-h reperfusion, bile
production was significantly higher in the Cs group as compared to
the no-HP group and the RL group (* p<0.05)
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vein was significantly lower in the no-HP group as
compared to the RL and Cs groups, 10 min after
reperfusion (Fig. 1b). Flow subsequently normalized in all
groups and no significant differences were found anymore.
Bile production
Baseline bile production was 35–40 mL/h. During TVE,
bile production decreased to almost zero (Fig. 1c). After
release of the clamps, bile production gradually increased in
all groups. After 1-, 6-, and 12-h reperfusion, bile pro-
duction was significantly higher in the RL and Cs groups as
compared to the no-HP group. After 24-h reperfusion, bile
production was significantly higher in the Cs group as
compared to the no-HP and RL groups.
Microvascular perfusion
Microvascular perfusion, as measured by intrahepatic tissue
pO2 levels, decreased significantly 10 min after reperfu-
sion as compared to pre-TVE values in the no-HP group
(Fig. 2). After 1-h reperfusion, microvascular perfusion
was significantly increased in the Cs group as compared to
before TVE. This relative hyperperfusion also occurred to
a lesser extent in the RL group but not in the no-HP group.
After 24-h reperfusion, intrahepatic tissue pO2 levels had
normalized in all groups.
Glutathione levels
After reperfusion, liver tissue glutathione significantly
decreased in the no-HP group as compared to pre-TVE
(Fig. 3a). This did not occur in the other groups. After
10-min and 6-h reperfusion, liver tissue glutathione was
significantly higher in the Cs group as compared to the
no-HP group. After 24-h reperfusion, liver tissue glutathi-
one was significantly higher in the RL and Cs groups as
compared to the no-HP group. Liver tissue glutathione was
also higher in the Cs group as compared to the RL group
after 24-h reperfusion. Liver tissue glutathione was signif-
icantly higher in the Cs group after 24-h reperfusion as
compared to pre-TVE. During reperfusion, bile glutathione
significantly increased in the RL and Cs groups as
compared to pre-TVE (Fig. 3b). After 6- and 24-h reperfu-
sion, bile glutathione was significantly higher in the RL and
Cs groups as compared to the no-HP group. Bile glutathi-
one was also significantly higher in the Cs group as
compared to the RL group after 24-h reperfusion. Plasma
glutathione levels during reperfusion showed no differences
Fig. 2 Intrahepatic tissue pO2 levels before TVE and during
reperfusion. Intrahepatic tissue pO2 was significantly lower in the
no-HP group (black bars) as compared to the RL (grey bars) and Cs
(white bars) groups (* p<0.01) after 10-min and 1-h reperfusion.
# Significantly different from pre-TVE (p<0.05)
Fig. 3 Liver tissue (a) and bile (b) glutathione concentration, measured
before TVE and during reperfusion. a After 10-min and 6-h reperfusion,
liver tissue glutathione was significantly higher in the Cs group as
compared to no-HP (* p=0.042). After 24-h reperfusion, liver tissue
glutathione was significantly higher in the RL as compared to no-HP
(* p<0.05) and also in the Cs group as compared to RL and no-HP
(** p<0.02). b After 6- and 24-h reperfusion, bile glutathione was
significantly higher in the RL and Cs groups as compared to the no-HP
group (* p<0.05). Bile glutathione was also significantly higher in the
Cs group as compared to the RL group after 24-h reperfusion (** p=
0.031). # Significantly different from pre-TVE (p<0.05)
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between groups nor when compared to pre-TVE values
(data not shown).
Coagulation parameters
The function of the coagulation system, as assessed by PT,
significantly decreased at all time points after TVE in all
groups (Fig. 4a). After 12- and 24-h reperfusion, PT was
significantly prolonged in the no-HP group as compared to
the RL and Cs groups. After 24-h reperfusion, PT was also
significantly higher in the RL group as compared to the Cs
group. Only in the Cs group, PT values almost returned to
baseline values after 24-h reperfusion. Activation of
coagulation, leading to thrombin generation, as measured
by plasma TAT complexes, was significantly increased at
all time points during reperfusion as compared to before
TVE in all groups (Fig. 4b). After TVE, TAT complexes
were significantly higher in the no-HP group as compared
to the RL and Cs groups. No statistical differences in TAT
complexes were found between RL and Cs groups.
Discussion
The effect of in situ HP using Celsior solution, a relatively
new organ preservation solution, was compared with HP
using Ringer-lactate and no-HP during 60-min TVE of
porcine liver. The advantage of HP during TVE was
confirmed in this study and is in agreement with other
reports [7–12]. Although no differences in parenchymal
damage and microcirculatory perfusion were found, HP
with Celsior solution resulted in less decrease of arterial pH
and base loss, better restoration of bile production, more
radical scavenging capacity, and better maintenance of
coagulation capacity as compared to HP with Ringer-lactate
solution. Hence, HP with Celsior solution is advantageous
over HP with Ringer-lactate solution. The arterial pH drop
and base loss observed directly after reperfusion was
probably caused by the onset of anaerobic glycolysis due
to the lack of oxygen. This leads to metabolic acidosis
secondary to the formation of lactate. Whereas acidotic pH
can protect against anoxic cell death, reperfusion of
ischemic cells at acidotic pH leads to more cell killing
(pH paradox) [27, 28]. The minor decrease in arterial pH
and base loss in the Celsior group as compared to the
Ringer-lactate group is most likely caused by the histidine
buffer contained in Celsior. Ringer-lactate solution does not
have a buffer capacity and has a low pH (6.0) by itself.
Formation of reactive oxygen species is an important
step in the onset of I–R damage [5, 6]. Reduced glutathione
is known to be a potent radical scavenger and has shown
the ability to reduce I–R damage in different models [29,
30]. Increased radical scavenging capacity in HP with
Celsior solution, as shown by total liver glutathione levels,
was most pronounced after 24-h reperfusion but was
already visible after 10-min reperfusion. It is hypothesized
that the reduced glutathione in Celsior solution was directly
oxidized in the liver during TVE. As known from literature,
oxidized glutathione is excreted into the bile [26]. Accord-
ingly, glutathione levels were most pronounced in the
Celsior group. It was seen earlier after reperfusion and
peaked after 24-h reperfusion. Peak values of liver and bile
glutathione after 24-h reperfusion probably better reflect the
restorative capacity of glutathione. Leakage of glutathione
from damaged cells into the systemic circulation did not
appear to be a major factor in this study, as no differences
were found in plasma glutathione levels after TVE as
compared to pre-TVE in all groups.
Microcirculatory disturbances within the liver were most
apparent directly after reperfusion. Hepatic artery and portal
venous flow as well as intrahepatic pO2 levels were
decreased after 10-min reperfusion and subsequently
recovered in the no-HP group. In the animals that did not
survive the experiments, this no-reflow state persisted and
was accompanied by massive congestion of the liver and
Fig. 4 Prothrombin time (a) and thrombin–antithrombin (TAT) com-
plexes (b) measured before TVE and during reperfusion. a PT was
significantly higher at all time points after reperfusion as compared to
before TVE in all groups (p<0.05). After 12- and 24-h reperfusion, PT
was significantly higher in the no-HP group as compared to the RL and
Cs groups (** p<0.05). After 24-h reperfusion, PT also was signifi-
cantly higher in the RL group as compared to the Cs group (* p=0.035).
b TAT complexes were significantly higher at all time points during
reperfusion as compared to before TVE in all groups (p<0.05). After 1-,
6-, 12-, and 24-h reperfusion, TAT complexes were significantly higher
in the no-HP group as compared to the RL and Cs groups (** p<0.05)
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noncorrectable systemic shock. Activation of coagulation is
also known to occur as part of I–R injury [31, 32]. The
formation of TAT complexes was significantly increased in
the no-HP group. HP with Celsior solution not only
resulted in reduction of the formation of TAT complexes,
but also PT was almost normalized within 24 h of
reperfusion. So HP with Celsior solution leads to faster
restoration of liver synthesis function as compared to HP
with Ringer-lactate, while coagulation activation is equally
reduced. The restoration of liver synthesis function by
Celsior, measured with PT, is remarkable and has not been
described previously.
From organ preservation studies it is known that
additives such as energy supplements, pH buffer, and
membrane stabilizers can decrease cold ischemic damage
and prolong preservation periods [13]. Although organ
preservation solutions such as University of Wisconsin
(UW) solution have been used for HP, no comparative
studies with Ringer-lactate have been performed [9, 10].
Currently, many consider UW solution as the gold standard
in organ preservation. In our experience, however, UW has
some disadvantages. Due to the colloid hydroxyethyl
starch, UW solution has a relatively high viscosity, ren-
dering it difficult to use as a washout solution. Further-
more, it is an intracellular type solution containing a high
potassium concentration (120 mmol/L). Therefore, it is
potentially dangerous to use in situ because of the risk of
cardiac arrhythmias when UW is spilled into the systemic
circulation. Celsior solution is a relatively new organ
preservation solution with a lower potassium concentration
(15 mmol/L) and lower viscosity than UW solution. We
therefore decided to use Celsior solution in this study.
In humans, in situ HP of the liver during TVE resulted in
a drastic reduction of parenchymal damage during liver
resection and decreased post-operative complications [9].
Although TVE may only be needed in complex liver
resections, it is advised to use HP during TVE, even when
the expected duration of TVE is below 60 min. The safe
limit for vascular inflow occlusion during partial liver
resections has not been defined. A period of 60 min is
considered to be relatively safe in humans, depending on
quality of the liver parenchyma [33]. In our pig model,
however, TVE for 60 min without HP resulted in a 33%
mortality rate (3/9). When, during pilot experiments, TVE
duration was extended to 90 min, no animals survived
(0/3). These results confirm the fact that the pig liver is
more susceptible to I–R damage than the human liver, and
in order to test different perfusion solutions, a period of
60-min TVE suffices in the pig model.
In conclusion, the protective effect of in situ HP during
TVE was confirmed in this study. Furthermore, whereas no
difference in parenchymal damage or microcirculatory
disturbances were found, HP with Celsior solution was
more effective in reducing metabolic acidosis, restoring
radical scavenging capacity and bile production, and
maintaining coagulation capacity as compared to HP with
Ringer-lactate. Therefore, when applying HP in humans,
Celsior is considered the preferred perfusion solution.
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